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ABSTRACT
Background: This is a study to determine if M2 Pyruvate Kinase (M2-PK) can be used to screen the presence 
RIERZHOLQÀDPPDWLRQ
Method: The study design being used was diagnostic test. In this study, we recruited 76 participants and 
performed colonoscopy examination as a gold standard and faecal M2-PK as the examined procedure.
Results: )URPWKHUHVXOWRIWKLVVWXG\ZHLGHQWL¿HGWKHLPSRUWDQWUROHRI03.WRVFUHHQWKHSUHVHQFHRI
ERZHOLQÀDPPDWLRQZLWKWKHFXWRIISRLQWRI8P/FRPSDUHGWRFRORQRVFRS\DVJROGVWDQGDUGZLWKWKH
VHQVLWLYLW\RIVSHFL¿FLW\SRVLWLYHSUHGLFWLYHYDOXHDQGQHJDWLYHSUHGLFWLYHYDOXH
Conclusion: )URPWKHUHVXOWRIWKLVVWXG\ZHVXJJHVWHG03.H[DPLQDWLRQWRVFUHHQERZHOLQÀDPPDWLRQ
in patients with lower gastrointestinal tract problems.
Keywords:03\UXYDWHNLQDVHFRORQRVFRS\VFUHHQLQJLQWHVWLQDOLQÀDPPDWLRQ
ABSTRAK
Latar belakang: Penelitian ini adalah suatu studi untuk menentukan apakah M2 Piruvat kinase (M2-PK) 
dapat dipakai dalam menapis radang usus.
Metode: Penelitian yang digunakan adalah uji diagnostik. Pada penelitian ini direkrut sampel sebanyak 
76 orang dan dilakukan pemeriksaan kolonoskopi sebagai baku emas dan pemeriksan M2-PK feses sebagai 
pemeriksaan yang diuji.
Hasil: Dari hasil penelitian ini didapatkan peran penting M2-PK untuk menapis radang usus dengan nilai 
titik potong 1,05 U/mL dibandingkan dengan kolonoskopi sebagai baku emas dengan sensitivitas 86,2 %, 
VSHVL¿VLWDVQLODLGXJDSRVLWLIGDQQLODLGXJDQHJDWLI
Simpulan: Pemeriksaan M2 Piruvat Kinase disarankan dari hasil studi ini untuk menapis radang usus pada 
pasien dengan masalah saluran cerna bagian bawah.
Kata kunci: M2 Piruvat kinase, kolonoskopi, penapisan, radang usus.
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INTRODUCTION
&OLQLFDO GLIIHUHQFH EHWZHHQ LQÀDPPDWRU\ ERZHO
GLVHDVHVZLWKQRQLQÀDPPDWRU\ERZHOGLVHDVHVVXFK
as irritable bowel syndrome (IBS) is a common problem 
IRXQGLQGDLO\SUDFWLFH7KLVSUREOHPEHFRPHVGLI¿FXOW
because both frequently appear with similar clinical 
manifestations, including bloating, stomachache, and 
diarrhea. These conditions sometimes need clinical 
evaluation, laboratory examination, and invasive 
examinations that are exhausting. The prototypes 
of inflammatory bowel disease (IBD) consist of 
Crohn’s disease (CD), ulcerative colitis (UC), and 
indeterminate colitis (IC). Diagnosis of IBD is highly 
GHSHQGHQWRQWKHFOLQLFDO¿QGLQJVWKDWDUHIRXQGDIWHU
performing radiological, endoscopy, and anatomy 
pathological examinations. Although the difference 
between UC and CD is quite clear clinically, 10-20% 
RIFDVHVFDQQRWEHFODVVL¿HGLQWRHLWKHURIWKHPDQG
LVFODVVL¿HGDV,QGHWHUPLQDWH&ROLWLV (IC).1,2,3
,Q ,QGRQHVLD VRPHRWKHU LQÀDPPDWRU\GLVHDVHV
such as: colitis, ileitis, proctitis, and intestinal 
tuberculosis frequently happen. These conditions 
also need thorough examinations to confirm the 
diagnosis and administer prompt treatment. Therefore, 
there is a necessity to have an examination which 
is easy to perform and able to detect the presence 
RIDEQRUPDOLWLHV LQ WKH IRUPRI LQÀDPPDWLRQ LQ WKH
bowel. This examination is also expected to have good 
VHQVLWLYLW\ DQG VSHFL¿FLW\ WR WKH VXVSHFWHG GLVHDVH
One of the examinations, which is currently studied 
widely, is faecal examination to identify marker of 
ERZHOLQÀDPPDWLRQ7KLVPDUNHULVQRWLQYDVLYHDQG
UHODWLYHO\ HDV\ WR EH SHUIRUPHG7KH LQÀDPPDWRU\
marker is M2-PK. This marker is one of the isoforms 
of a pyruvate kinase enzyme that catalyse aerobic 
(glycolysis) examination in rapidly dividing cells. The 
dimeric form of M2-PK can express cancer cells, which 
can be detected in the plasma. Currently, this marker is 
used as a tool to detect the presence of colon cancer.1,2,3,4
However, in several other studies, M2-PK is proved 
WREHDEOHWRUHYHDOWKHSUHVHQFHRILQÀDPPDWLRQLQ
WKHERZHOVXFKDVLOHDOSRXFKLQÀDPPDWLRQ5,6,7 Other 
studies comparing the level of M2-PK in patients 
ZLWK LQÀDPPDWRU\ ERZHO GLVHDVH VXFK DV ,%' WR
SDWLHQWVZLWKQRQLQÀDPPDWRU\ERZHOGLVHDVHVKRZHG
WKDWWKHUHZDVVLJQL¿FDQWGLIIHUHQFHLQWKHUHVXOWVRI
M2-PK.8 If examination using protein marker from 
WKHIDHFHVFDQEHXVHGWRSUHVHQWLQÀDPPDWLRQLQWKH
bowel, then invasive examinations, such as endoscopy, 
which require high cost and cause inconvenience 
can be conducted in more selective manner. This is 
EHQH¿FLDO IRUERWKGRFWRUVDQGSDWLHQWV'RFWRUFDQ
diagnose disease properly and patient becomes more 
comfortable and does not need to spend high cost 
for examinations. Besides, this study can also be a 
reference to studies on determinants to differentiate 
LQÀDPPDWRU\ERZHOGLVHDVHV DQGQRQLQÀDPPDWRU\
bowel diseases.9
METHOD
The design of this study was a diagnostic test 
study with numerical data on the level of M2-PK in 
LQÀDPPDWRU\ ERZHO GLVHDVH DQG QRQLQÀDPPDWRU\
bowel disease patients’ faecal specimen. This study 
was conducted to outpatient and hospitalized patients 
in the Gastroenterology Division, Internal Medicine 
Department, Faculty of Medicine, University of 
Indonesia/Cipto Mangunkusumo Hospital and 
several other hospitals in 2012. The population of the 
study were patients with lower gastrointestinal tract 
V\PSWRPVLQFOXGLQJLQÀDPPDWRU\ERZHOGLVHDVHRU
QRQLQÀDPPDWRU\ERZHOGLVHDVHVXFKDVIXQFWLRQDO
bowel disorder and functional abdominal pain 
syndrome according to Rome III criteria. Accessible 
population was all patients with lower gastrointestinal 
tract complaints in Cipto Mangunkusumo Hospital and 
several other hospitals nearby. Study samples were 
patients who came to the hospital after undergoing 
colonoscopy procedure. Samples were recruited 
according to the inclusion and exclusion criteria. Study 
samples were included consecutively.
Inclusion criteria were patients with lower 
gastrointestinal tract problem aged > 18 years old; 
patients who came in the January-June 2012 period; 
patients who agreed to participate in the study and had 
signed the informed consent. Exclusion criteria were 
colon cancer, polyp adenoma, and hyperplastic. Sample 
size in this study was 76. Data was evaluated to obtain 
WKH VHQVLWLYLW\ VSHFL¿FLW\ SRVLWLYHSUHGLFWLYHYDOXH
and negative predictive value. Appraisal of association 
and correlation between variables were evaluated by 
Chi-square test, using statistical program for social 
sciences (SPSS) for Windows version 17.
7R DOO SRWHQWLDO FDQGLGDWHVZKR IXO¿O LQFOXVLRQ
criteria, explanation on the procedure, study objectives, 
and purpose of examination were given. Later they 
were asked for consent to participate in the study in 
written from patient or patient’s family who were 
responsible for them. They were then submitted to the 
Ethical Committee Faculty of Medicine Universitas 
Indonesia for ethical clearance.
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RESULTS
In this study, there were 76 patients with varied 
background. Study subjects were recruited from six 
hospitals in Jakarta. There were more male patients 
compared to female patients, with the ratio of 57.9%: 
42.9%. In regard to race, it was seen that most of them 
were Chinese and Javanese. Possible reasons of most 
patients came from these two races was the location of 
sample collection in several private hospitals. In this 
study, it was unintentional that there were no recruited 
patients were in the age group of 18-24 years old. The 
productive age group was the most recruited in this 
study.
Table 1. Patients’ Characteristics
Variables n (%)
Gender
Male
Female
44 (57.9)
32 (42.1)
Race
Javanese
Sundanese
Padang
Batak
Chinese
Others
16 (21.2)
7 (9.2)
6 (7.9)
7 (9.2)
33 (43.4)
7 (9.2)
Age groups (years old) 
18-24
25-31
32-38
39-45
46-52
53-59
60-66
> 66
0 (0)
6 (7.9)
9 (11.8)
10 (13.2)
19 (25.0)
15 (19.7)
10 (13.2)
7 (9.2)
7DEOH. Indication of Colonoscopy Examination
Indication n (%)
Haematochezia 7 (9.2)
Stomachache 47 (61.7)
Constipation 2 (2.6)
Chronic diarrhea 34 (44.7)
IBS 8 (10.5)
Screening 3 (3.9)
The most common indications for colonoscopy 
were stomachache 61.7 %, followed by chronic 
diarrhea in 34% subjects and IBS in 10.5%. Other noted 
indications of examination include haematochezia, 
screening, and constipation.
Table 3.5HVXOWVRI&RORQRVFRS\)LQGLQJV
&RORQRVFRS\¿QGLQJV n (%)
Normal 11 (14.5)
Infective Colitis 21 (27.6)
Tumour 2 (2.6)
,QÀDPPDWRU\SRO\S 24 (31.6)
Ulcerative colitis 3 (3.9)
Crohn’s Disease 2 (2.6)
Ileitis 7 (9.2)
Diverticulosis 7 (9.2)
IBD 1 (1.3)
Haemorrhoid 55 (72.4)
Table 4.&URVV WDEXODWLRQVEHWZHHQ UHVXOWVRI FRORQRVFRS\
¿QGLQJVZLWK03.OHYHO
&RORQRVFRS\¿QGLQJV Total,QÀDPPDWRU\ 1RQLQÀDPPDWRU\
,QÀDPPDWRU\
03.
56 2 58
1RQLQÀDPPDWRU\
(M2PK < 1,05)
9 9 18
Total 65 11 76
From table 5.4, the obtained sensitivity value was: 
[ VSHFL¿FLW\YDOXH
x 100% = 81.8%; positive predictive value= 56/ (56+2) 
x 100% = 96.6%; negative predictive value: 9/ (9+9) 
x 100 %= 50%.
From ROC curve, it is seen that this M2-PK 
H[DPLQDWLRQUHYHDOHGJRRGVHQVLWLYLW\DQGVSHFL¿FLW\
value.
7DEOH$UHD8QGHUWKH&XUYH$8&
Area Std. Errora P Asymptomatic 95% CI/RZHUOHYHO Upper level
.834 .079 .000 .679 .990
From the calculation results of SPSS 17, it was 
obtained that the area under the curve (AUC) value 
was 83.4 % in 95% CI (67.9%-99%). This AUC value 
VKRZHG WKDW WKLV H[DPLQDWLRQ KDG JRRG EHQH¿W WR
FRQ¿UPGLDJQRVLV
DISCUSSION
According to the study performed by Joshi S, the 
value of M2-PK in healthy individuals were < 1 U/
mL regardless of their age.10 From this study, we 
obtained the value of M2-PK 1.05 U/mL, as a cut-off 
value to determine if someone suffered from bowel 
LQÀDPPDWLRQRUQRW7KHUHVXOWVRIWKLVVWXG\VXSSRUWHG
the study by Joshi et al that M2-PK value could be used 
to determine whether someone suffered from bowel 
LQÀDPPDWLRQRUQRW)URP WKH UHVXOWVRI WKLV VWXG\
according to the performed analysis with the cut-off of 
8P/RWKHUYDOXHVVXFKDVVHQVLWLYLW\VSHFL¿FLW\
positive predictive value, and negative predictive value 
were calculated.
Jeffrey J et al in their study obtained the sensitivity 
YDOXHWREHVSHFL¿FLW\SRVLWLYHSUHGLFWLYH
likelihood ratio 5.6, and negative predictive likelihood 
ratio 0.18.8 This data was slightly different to the 
data obtained in this study, which could possibly be 
caused by the different study design being used. From 
this data, we could evaluate that the sensitivity value 
was 86.2% which showed that this examination was 
quite sensitive to detect the presence of intestinal 
DEQRUPDOLW\7KHVSHFL¿FLW\YDOXHRIUHYHDOHG
Volume 16, Number 1, April 2015 25
The Role of M2 Pyruvate Kinase in the Screening of Bowel Inflammation
that this examination was quite good to determine if 
a patient was healthy if the examination result was 
negative.
With the positive predictive value of 96.6%, it also 
showed that if the examination result was positive, the 
possibility the patient was sick was very high; thus, 
it would be best if this examination was used as a 
screening tool in cases of lower gastrointestinal tract 
problems, which would enable general screening to 
patients. The lower value of negative predictive value, 
only 50% revealed that if the examination result was 
negative, the possibility of the patient not suffering 
from colonoscopy abnormalities was only half, 
therefore other examination was needed to support this 
examination as a supporting examination to eliminate 
differential diagnosis.
At the end of this study, we reviewed on the 
inference of these study results on the possibility 
to be applied in larger population. According to the 
principles of sample representation to population and 
sample collecting technique, generalization appraisal 
ZDV SHUIRUPHG WR WKH LQWHUQDO DQG¿UVW DQG VHFRQG
external validities. Internal validity appraisal was 
performed by examining if subjects who completed 
the study (actual study subjects) could represent the 
VDPSOHVWKDWIXO¿OOHGWKHVXEMHFWUHFUXLWPHQWFULWHULD
(intended subjects). In this study, all subjects who 
fulfilled the subject recruitment criteria could be 
included as study sample. Therefore, the internal 
validity of this study was good.
)RU¿UVWH[WHUQDOYDOLGLW\DSSUDLVDOZDVSHUIRUPHG
towards subject representation that was recruited 
according to the sample recruitment criteria (intended 
sample) towards to accessible population. Accessible 
population in this study was patients who visited the 
gastroentero-hepatology outpatient clinic with the 
complaint of lower gastrointestinal tract. Sampling 
WHFKQLTXHLQSDWLHQWVZKRIXO¿OOHGWKHLQFOXVLRQFULWHULD
was consecutive sampling. This sampling technique 
was the best non-random sampling to represent the 
DFFHVVLEOHSRSXODWLRQ%DVHGRQWKLVWKH¿UVWH[WHUQDO
validity of this study was good. 
For second external validity, appraisal was 
performed by common sense and based on general 
knowledge if available. In this matter, it was evaluated 
if the accessible population of this study was the best 
representation of the target population. By calculating 
that the accessible population was population of 
patients with lower gastrointestinal tract complaints 
in big hospitals that had tertiary care facility, such 
as gastrointestinal tract endoscopy, then the patients’ 
characteristics were relatively similar to other patients’ 
characteristics in other hospitals that had endoscopy 
facility. From this result, we concluded that the second 
external validity was good.
CONCLUSION
M2-PK can be used as an aid to screen the presence 
RI LQÀDPPDWRU\ ERZHOZLWK WKH FXWRII YDOXH RI 
1.05U/mL. This M2-PK examination can be used 
selectively in patients with lower gastrointestinal tract 
complaints.
REFERENCES
1. Hardt PD, Mazurek S, Toepler M, Schlier P, Bretzer RG, 
Eigenbrodt E, et al. Faecal tumour M2 pyruvate kinase: a 
new, sensitive screening tool for colorectal cancer. Br J Cancer 
2004;91:980-4.
2. +DXJ8+XQGW6%UHQQHU+6HQVLWLYLW\DQGVSHFL¿FLW\RI
faecal tumour M2 pyruvate kinase for detection of colorectal 
adenomas in a large screening study. Br J Cancer 2008;99:133-
5.
3. Kumar Y, Tapuria N, Kirmani N, Davidson. Tumour M2-
pyruvate kinase: a gastrointestinal cancer marker. Eur J 
Gastroen Hepat 2007;19:265-274.
4. Gupta V, Bamezai RN. Human pyruvate kinase M2: A 
multifuntional protein. Protein Sci 2010;19:2031-44.
5. Walkowiak J, Banasiewicz T, Krokowicz P, Hansdorver-
Korzon R, Drews M, Herzig KH. Fecal pyruvate kinase (M2-
3.$QHZSUHGLFWRUIRULQÀDPPDWLRQVHYHULW\RISRXFKLWLV
Scand J Gastroenterol 2005;40:1493-4.
6. Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Ciclitira 
PJ, Sherwoon RA, et al. Faecal M2-pyruvate kinase: a novel, 
noninvasive marker of ileal pouch inflammation. Eur J 
Gastroenterol Hepatol 2009;21:544-50.
7. Chung-Faye G, Hayee B, Maestranzi S, Donaldson N, 
Forgacs I, Sherwood R. Fecal M2-pyruvate kinase (M2-PK): 
$QRYHOPDUNHURILQWHVWLQDOLQÀDPPDWLRQ,QÀDPP%RZHO
Dis 2007;13:1374-8.
8. Jefferey J, Lewis SJ, Ayling RM. Fecal dimeric M2-pyruvate 
kinase (tumor M2-PK) in the differential diagnosis of 
IXQFWLRQDODQGRUJDQLFERZHOGLVRUGHUV,QÀDPP%RZHO'LV
2009;15;1630-4.
9. 'MRMRQLQJUDW',QÀDPPDWRU\ERZHOGLVHDVH$OXUGLDJQRVLV
dan pengobatannya di Indonesia. In: Sudoyo AW, Setiyohadi 
B, Alwi I, Simadibrata M, Setiati S, eds. Buku Ajar Ilmu 
Penyakit Dalam. Jilid II. 4th ed. Jakarta: Interna Publ 
2006.p.384-8.
10. Joshi S, Lewis SJ, Creanor S, Ayling RM. Age-related faecal 
calprotectin lactoferrin and tumour M2-PK concentrations in 
healthy volunteers. Annals of Clin Biochem 2010;47:259-63.
